Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, Davis
Emory University
University of Texas Southwestern Medical Center
University of Washington
University of California, San Francisco
Milton S. Hershey Medical Center
Dana-Farber Cancer Institute
NRG Oncology
University of California, Davis
Thomas Jefferson University
University of Colorado, Denver
Emory University
Mayo Clinic
Stanford University
Herlev Hospital
Institute of Cancer Research, United Kingdom
M.D. Anderson Cancer Center
Indiana University
Duke University
Hoosier Cancer Research Network
Yale University
University of Chicago
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
University of Wisconsin, Madison
Albert Einstein College of Medicine
City of Hope Medical Center
Vanderbilt University Medical Center
Rutgers, The State University of New Jersey
University of Nebraska
Ludwig Institute for Cancer Research
Dartmouth-Hitchcock Medical Center
University of Florida
UNC Lineberger Comprehensive Cancer Center
Peter MacCallum Cancer Centre, Australia
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
University of Wisconsin, Madison
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute
Duke University
Hoosier Cancer Research Network
City of Hope Medical Center
Academic and Community Cancer Research United
Weill Medical College of Cornell University